Skip to main content
. 2019 Oct 24;135(4):261–268. doi: 10.1182/blood.2019001793

Table 2.

Concordance rates according to any mutation, DNMT3A, TET2, “DTA mutations,” and maximum clone size <10%

MZ DZ
Number of pairs Concordant pairs Discordant pairs cc rate Number of pairs Concordant pairs Discordant pairs cc rate P for ccMZ = ccDZ
Variable N N N pc (95% CI) N N N pc (95% CI) P
Any mutation (yes/no) 81 20 61 0.40 (0.32; 0.49) 89 23 66 0.40 (0.32; 0.49) 1
TET2 mutation (yes/no) 35 4 31 0.20 (0.10; 0.34) 38 4 34 0.20 (0.10; 0.34) 1
DNMT3A mutation (yes/no) 41 6 35 0.25 (0.12; 0.43) 50 6 44 0.22 (0.11; 0.40) .86
“Only TET2/DNMT3A/ASXL1” vs “no mutation” 65 14 51 0.33 (0.24; 0.43) 63 11 52 0.33 (0.24; 0.43) 1
“Max VAF <10%” vs “no mutation” 57 11 46 0.28 (0.25; 0.32) 57 7 50 0.28 (0.25; 0.32) .99

Casewise concordance (cc) rates were calculated to estimate a genetic predisposition. If the cc rates are higher in the MZ twins compared with DZ twins, it indicates a genetic predisposition to the variable. We did not find any difference in the cc rates between MZ or DZ in any of the tested variables.